Email Alert RSS
Volume 15 Issue 2
Mar.  2024
Turn off MathJax
Article Contents
Abstract
References
XU Dong, CHEN Jiangyun, CAI Yiyuan. Past and Present of Implementation Science (PartⅠ)—Origin and Development[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 442-449. DOI: 10.12290/xhyxzz.2024-0023
Citation: XU Dong, CHEN Jiangyun, CAI Yiyuan. Past and Present of Implementation Science (PartⅠ)—Origin and Development[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 442-449. DOI: 10.12290/xhyxzz.2024-0023
shu

Past and Present of Implementation Science (PartⅠ)—Origin and Development

  • 1.

    Acacia Lab for Implementation Science, Department of Health Management, School of Health Management, Guangzhou 510515, China

  • 2.

    Southern Medical University Institute for Global Health (SIGHT), Dermatology Hospital of Southern Medical University, Guangzhou 510091, China

  • 3.

    Center for World Health Organization Studies, Southern Medical University, Guangzhou 510515, China

  • 4.

    Department of Epidemiology and Health Statistics, School of Public Health, Guizhou Medical University, Gui'an, Guizhou 561113, China

  • 5.

    The key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Gui'an, Guizhou 561113, China

Funds: 

National Natural Science Foundation of China 72164005

Swiss Agency for Development and Cooperation 81067392

More Information
  • Corresponding author:

    CAI Yiyuan, E-mail: caiyiyuan@gmc.edu.cn

  • Received Date: January 11, 2024
  • Accepted Date: February 19, 2024
  • Available Online: March 05, 2024
  • Issue Publish Date: March 29, 2024
    Graphical Abstract
    • Abstract
  • Implementation science aims to close the gap between knowledge and practice by fostering the uptake and implementation of evidence-based practices. In Europe and America, implementation science is rapidly evolving and improving. In China, the field is still in its infancy. This paper focuses on the definition, origin, domestic and international development, research hotspots, challenges, and opportunities of implementation science. Although implementation science is still at an early stage in China, it has shown rapid development momentum. Chinese scholars, therefore, should leverage China's distinctive research environment to conduct high-quality and innovation implementation studies in order to excel in implementation science areas and lead globally.
    • FullText(HTML)
    • References (23)
  • [1]
    Bauer M S, Kirchner J A. Implementation science: What is it and why should I care?[J]. Psychiatry Res, 2020, 283: 112376. DOI: 10.1016/j.psychres.2019.04.025
    [2]
    Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence[J]. Lancet, 2009, 374(9683): 86-89. DOI: 10.1016/S0140-6736(09)60329-9
    [3]
    National Institute of Health. Implementation science news, resources and funding for global health researchers[EB/OL]. [2024-02-16]. https://www.fic.nih.gov/researchtopics/pages/implementationscience.aspx.
    [4]
    Odeny T A, Padian N, Doherty M C, et al. Definitions of implementation science in HIV/AIDS[J]. Lancet HIV, 2015, 2(5): e178-e180. DOI: 10.1016/S2352-3018(15)00061-2
    [5]
    Eccles M P, Mittman B S. Welcome to implementation science[J]. Implement Sci, 2006, 1: 1. DOI: 10.1186/1748-5908-1-1
    [6]
    Eccles M P, Foy R, Sales A, et al. Implementation science six years on-our evolving scope and common reasons for rejection without review[J]. Implement Sci, 2012, 7: 71. DOI: 10.1186/1748-5908-7-71
    [7]
    Metz A, Jensen T, Farley A, et al. Is implementation research out of step with implementation practice? Pathways to effective implementation support over the last decade[J]. Implement Res Pract, 2022, 3: 26334895221105585.
    [8]
    Allison M, Albers B, Katie M, et al. Implementation Practice in Human Service Systems: Understanding the Principles and Competencies of Professionals Who Support Implementation[J/OL]. (2021-03-15)[2024-01-12]. https://www.tandfonline.com/doi/full/10.1080/23303131.2021.1895401.
    [9]
    Hoke T. Implementation research: The unambiguous cornerstone of implementation science[EB/OL]. (2018-02-06)[2024-01-12]. https://researchforevidence.fhi360.org/implementation-research-the- unambiguous-cornerstone-of-imple- mentation-science.
    [10]
    Mellis C. Evidence-based medicine: what has happened in the past 50 years?[J]. J Paediatr Child Health, 2015, 51(1): 65-68. DOI: 10.1111/jpc.12800
    [11]
    Lang E S, Wyer P C, Haynes R B. Knowledge translation: closing the evidence-to-practice gap[J]. Ann Emerg Med, 2007, 49(3): 355-363. DOI: 10.1016/j.annemergmed.2006.08.022
    [12]
    Glasgow R E, Vinson C, Chambers D, et al. National institutes of health approaches to dissemination and implementa-tion science: current and future directions[J]. Am J Public Health, 2012, 102(7): 1274-1281. DOI: 10.2105/AJPH.2012.300755
    [13]
    Wang Y X, Wong E L Y, Nilsen P, et al. A scoping review of implementation science theories, models, and frameworks-an appraisal of purpose, characteristics, usability, applicability, and testability[J]. Implement Sci, 2023, 18(1): 43. DOI: 10.1186/s13012-023-01296-x
    [14]
    The Lancet Global Health. Implementing implementation science in global health[J]. Lancet Glob Health, 2023, 11(12): e1827. DOI: 10.1016/S2214-109X(23)00523-5
    [15]
    Norton W E, Lungeanu A, Chambers D A, et al. Mapping the growing discipline of dissemination and implementation science in health[J]. Scientometrics, 2017, 112(3): 1367-1390. DOI: 10.1007/s11192-017-2455-2
    [16]
    国家自然科学基金委员会. 2017年度国家自然科学基金委员会(NSFC) 与加拿大卫生研究院(CIHR) 精神健康与痴呆症实施性合作研究项目指南[EB/OL]. (2016-12-30)[2024-01-12]. https://www.nsfc.gov.cn/publish/portal0/tab442/info61110.htm.

    National Natural Science Foundation of China. Notice of Approval for the 2017 National Natural Science Foundation of China (NSFC) and Canadian Institutes of Health (CIHR) collaborative research program on mental health and dementia implementation[EB/OL]. (2016-12-30)[2024-01-12]. https://www.nsfc.gov.cn/publish/portal0/tab442/info61110.htm.
    [17]
    Landes S J, McBain S A, Curran G M. An introduction to effectiveness-implementation hybrid designs[J]. Psychiatry Res, 2019, 280: 112513. DOI: 10.1016/j.psychres.2019.112513
    [18]
    Waltz T J, Powell B J, Matthieu M M, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study[J]. Implement Sci, 2015, 10: 109. DOI: 10.1186/s13012-015-0295-0
    [19]
    Gaynes B N, Akiba C F, Hosseinipour M C, et al. The Sub-Saharan Africa Regional Partnership (SHARP) for mental health capacity-building scale-up trial: study design and protocol[J]. Psychiatr Serv, 2021, 72(7): 812-821. DOI: 10.1176/appi.ps.202000003
    [20]
    Faija C L, Gellatly J, Barkham M, et al. Enhancing the behaviour change wheel with synthesis, stakeholder involve-ment and decision-making: a case example using the 'enhancing the quality of psychological interventions delivered by telephone' (Equity) research programme[J]. Implement Sci, 2021, 16(1): 53. DOI: 10.1186/s13012-021-01122-2
    [21]
    Bing A, Spiegelman D, Nevo D, et al. Learn-As-you-GO (LAGO) trials: optimizing treatments and preventing trial failure through ongoing learning[EB/OL]. (2023-07-13)[2024-02-16]. https://arxiv.org/abs/2307.06552.
    [22]
    Wiltsey Stirman S, Baumann A A, Miller C J. The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions[J]. Implement Sci, 2019, 14(1): 58. DOI: 10.1186/s13012-019-0898-y
    [23]
    Miller C J, Barnett M L, Baumann A A, et al. The FRAME-IS: a framework for documenting modifications to implementation strategies in healthcare[J]. Implement Sci, 2021, 16(1): 36.
    • Related Articles

  • Cited by

    Periodical cited type(6)

    1. 钟小芳，李雅，朱虹，孙致远，赵舒扬. 基于政策工具的我国抗肿瘤创新药物政策文件分析. 医药导报. 2024(04): 654-660 .
    2. 王潇，文敏，郑沛，刘秋叶，左亚杰. 土鳖虫化学成分和药理作用的研究进展及其质量标志物(Q-Marker)的预测分析. 环球中医药. 2024(05): 933-940 .
    3. 刘娟，李庆，朱胜钦，薛志勇. 3-甲基-6-氨甲基-喹喔啉-2-甲酸衍生物的合成. 合成化学. 2024(07): 622-626 .
    4. 巫建群，邓晓莉. 95例新型抗肿瘤药物不良反应分析. 海峡药学. 2024(11): 114-117 .
    5. 刘肃，刘颍，朱飞跃. 关于药品定期安全性更新报告审核的一点思考. 药品评价. 2024(10): 1174-1177 .
    6. 李佳新. 抗肿瘤药物的分类及不良影响研究现状. 人人健康. 2023(10): 99-101 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2219) PDF downloads (633) Cited by(8)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close